Samsung Bioepis Opens the New State-of-the-Art Headquarters to Accommodate Next Stage of Growth and Innovation

Samsung Bioepis New Headquarters Located in Korea’s ‘Bio Cluster’ of Songdo in the Incheon Free Economic Zone (IFEZ) The 52,000-square-foot campus to become the hub of Samsung Bioepis’ drive for accelerated development of next-generation biologic medicines Includes ‘Welfare Center’ with

Philips and Spanish healthcare group Vithas sign strategic agreement to incorporate Philips’ most advanced technologies into Vithas hospitals and clinics

January 25, 2021 5-year alliance will provide Vithas Group with state-of-the-art diagnostic imaging, image viewing solutions, and minimally-invasive intervention technology to deliver faster and more accurate diagnosis and treatment to patients Vithas will become a ‘reference technology partner’ for Philips

Philips and Rennes University Hospital sign 5-year technology, research and innovation partnership to advance patient care

January 25, 2021 Hospital will have access to Philips’ latest technologies and informatics solutions to enhance the diagnosis, treatment, monitoring and management of patients Multi-year strategic partnership will accelerate clinical research focused on image-guided minimally-invasive therapy, neurology, intensive care units

Philips delivers Q4 sales of EUR 6.0 billion, with 7% comp. sales growth; income from cont. operations increases to EUR 608 million, Adjusted EBITA margin improves 110 bps to 19.0%, and operating cash flow increases to EUR 1,305 million

January 25, 2021 Fourth-quarter highlights •        Sales amounted to EUR 6.0 billion, with 7% comparable sales growth •        Comparable order intake increased 7% •        Income from continuing operations increased to EUR 608 million, compared to EUR 550 million in Q4

FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma

SHANGHAI, China, Jan. 25, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that U.S. Food and Drug Administration (FDA) has granted toripalimab

Larry King, decades-long fixture of US TV interviews, dead at 87

 Larry King, who quizzed thousands of world leaders, politicians and entertainers for CNN and other news outlets in a career spanning more than six decades, has died aged 87, his media company said in a statement on Saturday. King had

One year since first COVID-19 lockdown, world gears up for vaccine

  Saturday marked one year since the COVID-19 pandemic triggered a lockdown in the Chinese city of Wuhan. The virus has now infected more than 99 million people across the globe and has killed more than 2.1 million. The US

No new COVID-19 cases reported in Vietnam

– Vietnam recorded no new COVID-19 cases in the past 2 days, according to the National Steering Committee for COVID-19 Prevention and Control.  Vietnam has so far reported 1,548 infections. As many as 1,411 patients were given the all-clear from coronavirus while the

Iran leaves door open for cooperation with US

– Iran would not allow the US to interfere in its internal affairs but may cooperate with the US on oil and security in the Gulf, Iranian foreign minister Mohammad Javad Zarif said in an interview with the Etmad newspaper on

US reaffirms alliance with South Korea, Japan

   US Defence Secretary Lloyd Austin on Sunday called South Korea’s Minister of National Defense Suh Wook to reaffirm the “ironclad alliance” between the two countries while emphasising on the importance of close cooperation between them. The two defense chiefs asserted